Digital Ophthalmic Healthcare Company Eyenovia Invests $50 Million to Establish HYPE Reserve

ChainCatcher reports that Eyenovia, a US Nasdaq-listed company specializing in digital ophthalmic medical technology, has announced the completion of a $50 million PIPE financing round. The funds will be used to purchase Hyperliquid’s native token HYPE, and the company plans to become one of its major global validator nodes.

The total fundraising cap for this transaction is expected to reach $150 million. The company will also be renamed “Hyperion DeFi,” with its stock ticker changed to “HYPD.” Newly appointed Chief Investment Officer Hyunsu Jung will be responsible for executing this crypto treasury strategy. Eyenovia will also continue to advance its FDA registration plan for ophthalmic devices, aiming for completion by September 2025.